| Alivus Life Sciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Long Term Debt-Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 3.70 | 3.65 | 3.78 | 1.90 | 1.00 |
| Fixed Assets | 2.14 | 2.34 | 2.63 | 3.13 | 3.02 |
| Inventory | 3.56 | 3.59 | 3.86 | 4.12 | 4.07 |
| Debtors | 2.75 | 2.90 | 2.92 | 3.28 | 3.00 |
| Interest Cover Ratio | 272.42 | 408.28 | 1143.93 | 21.20 | 6.38 |
| PBIDTM (%) | 30.05 | 30.06 | 31.06 | 29.71 | 31.40 |
| PBITM (%) | 27.51 | 27.72 | 29.11 | 27.92 | 29.63 |
| PBDTM (%) | 29.94 | 29.99 | 31.03 | 28.39 | 26.75 |
| CPM (%) | 22.89 | 22.97 | 23.55 | 21.51 | 20.42 |
| APATM (%) | 20.35 | 20.62 | 21.61 | 19.72 | 18.65 |
| ROCE (%) | 24.97 | 27.94 | 29.80 | 42.20 | 96.75 |
| RONW (%) | 18.86 | 21.07 | 22.28 | 29.83 | 60.91 |